EN 
ES
PT
TH
DE
TR
FR
Aabo UQ ailewu
Bi-iṣẹ ṣiṣe ẹjẹ glukosi ati eto iboju abojuto uric; Laifọwọyi awọn ila ejection; ISO15197 2013 fọwọsi; Koodu smart fun idanwo uric acid
Akopọ
Ailewu ẹjẹ AQ UG Ailera ati Eto Abojuto Apọju Acid A ṣe apẹrẹ fun wiwọn iwọn-ara ti glukosi ati uric acid ni awọn ẹjẹ ẹjẹ gbogbo awọn ayẹwo ẹjẹ ati ṣiṣapẹẹrẹ ẹjẹ awọn ayẹwo. Ailewu ẹjẹ AQ UG Ailera ati Eto Abojuto Apọju Acid jẹ fun lilo ni ita ara nikan (ni lilo iwadii aarun ayọkẹlẹ) fun idanwo ara-ẹni ati lilo amọdaju bi iranlọwọ ni iṣakoso ti àtọgbẹ ati hyperuricemia (HUA).
Specification
| Ṣiṣẹ Ṣiṣẹ | Ẹjẹ Glucose | Acid Uric |
|---|---|---|
| igbeyewo ọna | FAD-GDH | Oxidized Ferrocene itọsẹ |
| Ayẹwo apẹẹrẹ | Pipele ẹjẹ gbogbo ẹjẹ / ṣiṣọn ẹjẹ gbogbo ẹjẹ | Pipele ẹjẹ gbogbo ẹjẹ / ṣiṣọn ẹjẹ gbogbo ẹjẹ |
| Apeere ẹjẹ | 0.6µl | 3µl |
| Ipele idanwo | 20-600mg / dL (1.1-33.3mmol / L) | 3.0-20.0mg / dL 181-1188 µmol / L） |
| Akoko Idanwo | 5s | 25 |
| Memory | 500 tosaaju | 100 tosaaju |
| Wiwulo ipa | 24 osu | 17 osu |
Evaluation Ayẹwo iṣẹ ṣiṣe glukosi ẹjẹ:
| Awọn abajade fun awọn ifọkansi glukosi <100 mg / dL (<5.55mmol / l) | ||
|---|---|---|
| Laarin ± 5mg / dL (laarin ± 0.28mmol / l) | Laarin ± 10mg / dL (laarin ± 0.56mmol / l) | Laarin ± 15mg / dL (laarin ± 0.83mmol / l) |
| 50% (14 / 28) | 85.71% (24 / 28) | 100% (28 / 28) |
| Awọn abajade fun awọn ifọkansi glucose ≥ 100 mg / dL (≥5.55mmol / l) | ||
| Laarin ± 5% | Laarin ± 10% | Laarin ± 15% |
| 55.56% (40 / 72) | 90.28% （65 / 72) | 97.22% (70 / 72) |
Evaluation Imọye iṣẹ olumulo Uric acid:
| Awọn abajade fun awọn ifọkansi acid ur <297μmol / L (5.0 mg / dL) | ||
|---|---|---|
| Laarin ± 14.9μmol / L (Laarin ± 0.3 mg / dL) | Laarin ± 29.7μmol / L (Laarin ± 0.5 mg / dL) | Laarin ± 59.4μmol / L (Laarin ± 1.0 mg / dL) |
| 40.0% (6 / 15) | 60.0% (9 / 15) | 100% (15 / 15) |
| Awọn abajade fun awọn ifọkansi acid ur≥ 297μmol / L (5.0 mg / dL) | ||
| Laarin ± 5% 57.6% (49 / 85) | Laarin ± 10% 94.1% （80 / 85) | Laarin ± 15% 100% (85 / 85) |
